These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 5470523
1. An immunologic marker technique for the Cendehill vaccine strain of rubella virus. Oxford JS, Potter CW. J Immunol; 1970 Oct; 105(4):818-23. PubMed ID: 5470523 [No Abstract] [Full Text] [Related]
2. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells. Huygelen C, Peetermans J, Prinzie A. Prog Med Virol; 1969 Oct; 11():107-25. PubMed ID: 4984707 [No Abstract] [Full Text] [Related]
3. Prospects for a rubella virus vaccine. Parkman PD, Meyer HM. Prog Med Virol; 1969 Oct; 11():80-106. PubMed ID: 4984711 [No Abstract] [Full Text] [Related]
4. Genetic stability in humans of the rabbit immunogenic marker of Cendehill rubella vaccine virus. Gill SD, Furesz J. Arch Gesamte Virusforsch; 1973 Oct; 43(1):135-43. PubMed ID: 4793528 [No Abstract] [Full Text] [Related]
5. [Trials of vaccination against rubella with the Cendehill C-51 strain of live and attenuated virus]. Fara GM, Galli MG, Nodari R, Saccani CF, Marangoni L, Bozzetti A, Tarantino F. Minerva Med; 1970 Apr 14; 61(30 Suppl):1574-7. PubMed ID: 5439721 [No Abstract] [Full Text] [Related]
6. [Cendehill strain of live and attenuated rubella virus vaccine. Development, production and tests]. Peetermans J, Huygelen C. Minerva Med; 1970 Apr 14; 61(30 Suppl):1560-9. PubMed ID: 4985793 [No Abstract] [Full Text] [Related]
7. In vivo properties of attenuated rubella virus, "Cendehill" strain. Zygraich N, Peetermans J, Huygelen C. Arch Gesamte Virusforsch; 1971 Apr 14; 33(3):225-33. PubMed ID: 5000190 [No Abstract] [Full Text] [Related]
8. Attenuated rubella viruses. Laboratory and clinical characteristics. Meyer HM, Parkman PD, Hobbins TE, Larson HE, Davis WJ, Simsarian JP, Hopps HE. Am J Dis Child; 1969 Aug 14; 118(2):155-65. PubMed ID: 4978508 [No Abstract] [Full Text] [Related]
9. Studies on live rubella vaccine. I. Propagation of rubella virus in developing chick embryos and its laboratory characterization. Okuno Y, Minekawa Y, Suzuki N, Takahashi M. Biken J; 1968 Dec 14; 11(4):235-42. PubMed ID: 4976546 [No Abstract] [Full Text] [Related]
10. [Rubella. epidemiological studies and experiences with an attenuated vaccine ("Cendehill strain")]. Majer R. Helv Paediatr Acta; 1967 Dec 14; 22(6):579-90. PubMed ID: 4874394 [No Abstract] [Full Text] [Related]
11. Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations. Hilleman MR, Buynak EB, Whitman JE, Weibel RW, Stokes J. Am J Dis Child; 1969 Aug 14; 118(2):166-71. PubMed ID: 5815860 [No Abstract] [Full Text] [Related]
12. [Immunity and anti-rubella vaccination]. Delville JP, Tellini-Emma M. Arch Belg Med Soc; 1970 May 14; 28(5):321-30. PubMed ID: 5494764 [No Abstract] [Full Text] [Related]
13. Studies on live rubella vaccine. II. Field trials with two experimental vaccine strains. Minekawa Y, Suzuki N, Takahashi M, Okuno Y. Biken J; 1968 Dec 14; 11(4):243-50. PubMed ID: 5721530 [No Abstract] [Full Text] [Related]
14. Production of rubella virus vaccine. Live, attenuated in canine renal cell cultures. Musser SJ, Hilsabeck LJ. Am J Dis Child; 1969 Aug 14; 118(2):355-61. PubMed ID: 4978513 [No Abstract] [Full Text] [Related]
15. [Hemagglutinin of rubella virus: its characteristics and uses in epidemiology and clinical medicine]. Grasso A, Gagnoni G, Cantagalli P, Dianzani F, Piazzi SE. G Mal Infett Parassit; 1969 Jul 14; 21(7):603-15. PubMed ID: 5364953 [No Abstract] [Full Text] [Related]
16. Live, attenuated rubella-virus vaccine. Hilleman MR, Buynak EB, Weibel RE, Stokes J. N Engl J Med; 1968 Aug 08; 279(6):300-3. PubMed ID: 4969117 [No Abstract] [Full Text] [Related]
17. Results with the Cendehill rubella vaccine in postpartum women. Farquhar JD. Obstet Gynecol; 1970 Jun 08; 35(6):841-3. PubMed ID: 5463110 [No Abstract] [Full Text] [Related]
18. Live attenuated rubella virus vaccines in young adult women. Trials of Cendehill and HPV-77 DE-5. Byrne EB, Ryan JM, Randolph MF, Horstmann DM. Am J Dis Child; 1969 Aug 08; 118(2):234-6. PubMed ID: 4183351 [No Abstract] [Full Text] [Related]
19. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children. Naficy K, Nategh R, Ahangary S, Mohsenin H. Am J Dis Child; 1970 Dec 08; 120(6):520-3. PubMed ID: 5481902 [No Abstract] [Full Text] [Related]
20. Characteristics of an attenuated rubella virus strain (Cendehill). Huygelen C, Peetermans J. Prog Immunobiol Stand; 1967 Dec 08; 3():181-7. PubMed ID: 4985508 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]